D.A. Davidson & Co’s Surmodics SRDX Stock Holding History

D.A. Davidson & Co’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,000	Closed	-$28K	–	1868
2017 Q2	$28K	Sell	1,000 -1,000	-50%	-$24.1K	﹤0.01%	1725
2017 Q1	$48K	Buy	+2,000	New	+$49K	﹤0.01%	1537

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Teton Advisors Rye, New York $173M AUM 77.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

D.A. Davidson & Co's SRDX Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Surmodics (SRDX) in Q3 2017, closing a stake of 1,000 shares — an estimated $28K sold.

D.A. Davidson & Co first reported a position in SRDX in Q1 2017 and held it in 2 quarters. The position peaked at $48K in Q1 2017. 117 funds tracked by Wall St. Rank hold SRDX as of Q3 2017.

D.A. Davidson & Co reported no remaining Surmodics position as of Q3 2017 after selling out during the quarter.
D.A. Davidson & Co sold 1,000 Surmodics shares in Q3 2017, an estimated $28K.
D.A. Davidson & Co first reported a position in Surmodics in Q1 2017 and held it in 2 quarters.
D.A. Davidson & Co's Surmodics position peaked at $48K in Q1 2017.
117 funds tracked by Wall St. Rank held Surmodics as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.